The Meeting Worth Lobbying For: A “PRG” For Disease-Specific Review; NCI Plans Six.
Dana-Farber Picks Rosenthal To Direct New Center For Integrated Therapies.
Weinstein Receives Award; LRFA Honors Vincent Devita.
New Office For Protection Of Research Subjects Formed.
Marijuana Ingredient Promotes Tumor Growth, Study Finds.
Cvitkovic Responds To Story On March ODAC Meeting.
Trending Stories
- Trump administration seeks to slash NIH by roughly 40% as 27 institutes and centers are whittled down to eight
NCI to remain intact, but its finances are uncertain; FDA is spared big cuts - DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s Mercy
Whistleblower lawsuit alleges wrongful firing - Only half of adolescents and young adults with cancer get fertility counseling before treatment
Oncofertility consult is an oft-overlooked standard of care - Tom Sellers steps down as director of OHSU Knight, replaced by Lisa Coussens
Shivaani Kummar recently named interim CEO - NCI summarizes changes to the CCSG NOFO